{"id":"pf-07314470","rwe":[],"tags":[],"phase":"discontinued","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"discontinued","trials":["NCT06821750"],"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[{"date":"2025","type":"negative","milestone":"Phase 1 Initiated","description":"Phase 1 trial (A Study to Learn How Different Amounts of the Study Medicine Called PF-07314470 Are Tolerated and Ac) — Healthy. Trial terminated early."}],"aiSummary":"PF-07314470 is a novel antiviral agent; however, the specific mechanism of action and FDA-approved indication are not provided in the source material. Without complete information, a comprehensive clinical summary cannot be accurately generated.","brandName":"PF-07314470","companyId":"pfizer","ecosystem":[],"mechanism":{"target":"","novelty":"","modality":"","drugClass":"subcutaneous injection","explanation":"The information provided for PF-07314470 does not include the FDA mechanism of action or approved indication, making it impossible to create an accurate explanation of how this drug works. To provide reliable healthcare information, we would need details about its molecular target and therapeutic mechanism.\n\nPF-07314470 appears to be a Pfizer research compound, but without access to its mechanism classification or clinical trial data, any explanation would be speculative. If you have access to additional prescribing information, regulatory documents, or clinical trial results, those sources would provide the necessary details to explain this drug's function.\n\nFor accurate information about this medication, consult the FDA's official drug database, Pfizer's official documentation, or current medical literature on this compound.","oneSentence":"subcutaneous injection","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"Pfizer Inc.","competitors":[],"genericName":"pf-07314470","indications":{"approved":[],"offLabel":[],"pipeline":[{"name":"Healthy","phase":"discontinued","trialId":"","patients":null,"diseaseId":"unknown","trialName":"","primaryEndpoint":"","expectedCompletion":""}]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06821750","phase":"discontinued","title":"A Study to Learn How Different Amounts of the Study Medicine Called PF-07314470 Are Tolerated and Ac","status":"discontinued","sponsor":"Pfizer","isPivotal":false,"enrollment":23,"indication":"Healthy","completionDate":"2025-08","primaryEndpoint":"The purpose of this clinical trial is to learn if the study medicine (called PF-07314470) is safe and how it gets in and out of the body in healthy people."}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"crossReferences":{"chemblId":"CHEMBL4518706"},"formularyStatus":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Other"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"","enrichmentLevel":3,"visitCount":3,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}